Tailored outreach may be needed for some young cancer survivors
Growing numbers of patients are diagnosed with cancer between the ages of 15 and 39. These younger cancer patients can have complex health needs after their cancer treatment and should receive health care that includes screening for new cancers, addresses potential issues related to their treatment, ...
Featured News
Researchers study young cancer survivors and their opioid use.
Young cancer survivors were more likely to be on long-term opioid therapy when compared to their counterparts without cancer. But among those on long-term opioid therapy, young cancer survivors were ...
Algorithm improves MS treatment while reducing disparities
A novel treatment algorithm developed and implemented within Kaiser Permanente Southern California increased the use of effective medications for people with multiple sclerosis (MS), and reduced treatment ...
Five questions for … Dr. Navdeep Sangha
Navdeep S. Sangha, MD, is a vascular neurologist and co-assistant chief of Neurology at the Kaiser Permanente Los Angeles Medical Center. He is the director of the Kaiser Permanente Southern California ...
Moderna COVID-19 vaccine is effective 5 months after 2nd dose
November 29, 2021Kaiser Permanente research in Southern California published November 25, 2021, in The Lancet Regional Health – Americas confirmed high Moderna COVID-19 vaccine effectiveness up to 5 months after the second dose. Effectiveness was 87% against COVID-19 infection, 96% against COVID-19 hospitalization, and 98% against COVID-19 death. “This research provides reassuring evidence of the high effectiveness of ...Read more...Higher risk of dementia for older adults living with HIV
November 28, 2021A study reviewing 16 years of patient data found nearly double the rate of dementia among people with HIV compared with those without HIV. The rate of dementia decreased over time for both groups but remained higher for those with HIV, reported research published in the journal AIDS. The study compared more than 13,000 people with HIV, ages ...Read more...Exercise during pandemic linked to better mental health
November 10, 2021People who exercised more during the initial lockdown period of the COVID-19 pandemic experienced less anxiety and depression than those who didn’t exercise, according to new research published November 11, 2021, in Preventive Medicine. The research also showed that people who spent more time outdoors typically experienced lower levels of anxiety and depression than those ...Read more...Five questions for … Dr. Stanley Xu
November 10, 2021Dr. Stanley Xu is a senior research scientist biostatistician in the Division of Biostatistics Research in the Department of Research & Evaluation. He has served as principal investigator, co-investigator, and lead biostatistician on randomized trials and observational studies funded by the National Institutes of Health, Agency for Healthcare Research and Quality, Centers for Disease Control ...Read more...Kaiser Permanente members invited to join flu vaccine study
October 27, 2021The Centers for Disease Control and Prevention has selected Kaiser Permanente Southern California as a new site in its U.S. Flu Vaccine Effectiveness network. Kaiser Permanente Southern California is inviting its members to participate in a nationwide study of how well flu and COVID-19 vaccines are working. It is one of 2 new sites selected by ...Read more...New study looking at millions of vaccinated and unvaccinated people found no increased risk of death among COVID-19 vaccine recipients
October 22, 2021COVID-19 vaccine recipients had lower non-COVID-19 death rates than people who weren’t vaccinated, according to Kaiser Permanente research published Oct. 22, 2021 in the Centers for Disease Control and Prevention’s Morbidity and Mortality Weekly Report. “Despite numerous studies showing the safety of COVID-19 vaccines, some people have remained hesitant to get vaccinated,” said lead author Stanley ...Read more...Kaiser Permanente study to assess COVID-19 antibodies in employees, physicians
October 22, 2021A physician investigator in the Southern California Permanente Medical Group received a grant to study antibody responses to COVID-19 vaccination among health care workers. The study will also help learn more about the impact of booster vaccination and the rates of asymptomatic COVID-19 infection among the vaccinated. Kaiser Permanente Southern California is inviting up to 2,000 ...Read more...Five questions for … Dr. Debbie Malden
October 19, 2021Debbie Malden, DPhil, MSc, is an epidemiologist with research experience in large-scale prospective cohort studies. Before joining Kaiser Permanente, Dr. Malden completed her DPhil at the University of Oxford, assessing risk factors for cardiovascular disease among a half million U.K. adults using both observational and genetic epidemiological techniques. In addition to her research on chronic disease, ...Read more...Sleep aids increase fracture risk in breast cancer survivors
October 8, 2021About 40% of breast cancer survivors use prescription medications to alleviate sleep problems, but these medications can increase their risk of bone fractures, according to research from Kaiser Permanente in Southern California published Sept. 29, 2021 in Breast Cancer Research and Treatment. For many of the 3.8 million breast cancer survivors living in the United States, getting ...Read more...COVID-19 delta variant associated with increased risk of severe disease
October 7, 2021Researchers from the Centers for Disease Control and Prevention and Kaiser Permanente Southern California found that COVID-19 cases caused by the delta variant increased rapidly from April 15 to July 21, particularly among people ages 18 to 44. The study was published October 7, 2021, in the CDC’s Morbidity and Mortality Weekly Report, known as MMWR. ...Read more...